Dec. 19, 2024

The New York State Radiological Society (NYSRS) joined other medical organizations to voice strong opposition to legislation (S8485B/A9232B) that would significantly expand damages recoverable in medical wrongful death lawsuits. Passed during the 2024 legislative session, the bill was sent to Gov. Kathy Hochul for consideration. If enacted, the measure could have far-reaching consequences for physicians, patients and the state’s healthcare system as a whole.

This is the third time the legislature approved such a proposal, despite lawmakers’ concerns over its potential impact. New York already struggles to retain and recruit physicians, particularly in high-risk specialties, and added costs from drastically increased financial damages could exacerbate doctor shortages, limiting access to care for patients. Gov. Hochul vetoed the past legislation citing its broad implications.

Recognizing the stakes, NYSRS is again taking action to ensure the governor understands the critical need to reject this legislation. The society issued a membership-wide call to action Dec. 16, to emphasize that the burden threatens the overall stability of New York’s healthcare system.

For more information or if your state chapter needs help with a grassroots advocacy campaign, contact Melody Ballesteros, American College of Radiology® Assistant Director, Radiology Advocacy Network and RADPAC.

Related ACR News

  • State Legislatures Are Active As May Begins

    The American College of Radiology® (ACR®) is providing this weekly update on state bills as many state legislatures look to the end of their legislative sessions in the month of May.

    Read more
  • ACR Attends April 2025 RUC Meeting

    The ACR® participated in the American Medical Association/Specialty Society RVS Update Committee (RUC) meeting where they heard an update on the AMA’s Physician Practice Information Survey.

    Read more
  • Senate Committee Hearing Covers Concerns Related to Biomedical Research

    The U.S. Senate Committee held a hearing to discuss the importance of U.S. biomedical research for the nation’s health and economy.

    Read more